Maintenance of blood pressure control and left ventricular performance with small doses of enalapril

American Journal of Cardiology

Volumn 83, Issue 5, 1999, Pages 719-723

  González Juanatey, José Ramón ^a   Reino, Antonio Pose ^a   García Acuña, José María ^a   González Juanatey, Carlos ^a   Valdes, Luis ^a   De La Peña, Miguel Gil ^a   Cabezas Cerrato, José ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; DRUG EFFECT; DRUG MECHANISM; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; HEART VENTRICLE PERFORMANCE; HEART VENTRICLE SEPTUM; HUMAN; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; QT INTERVAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENALAPRIL; EXERCISE TEST; EXERTION; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MONITORING, AMBULATORY; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 0345435033     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00977-1     Document Type: Article

References (23)

1. Dzau V.J. Molecular and physiological aspects of tissue renin-angiotensin system emphasis on cardiovascular control . J Hypertens. 6:(suppl 3):1988;7S-12S.
2. Luscher T.E., Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol. 24:(suppl 3):1994;16S-26S.
3. Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. N Engl J Med. 323:1990;27-36.
4. Heagerty A.M., Aalkjaer C., Bund S.J., Korsgaard N., Mulvany M.J. Small artery structure in hypertension dual process of remodeling and growth . Hypertension. 21:1993;391-397.
5. Schiffrin E.L. Effect of antihypertensive therapy on small artery structure in hypertensive patients. Hypertension. 26:1995;716-717.
6. Thybo N.K., Stephens N., Cooper A., Aalkjaer C., Heagerty A.M., Mulvany M.J. Effect of antihypertensive therapy on small arteries of patients with previously untreated essential hypertension. Hypertension. 25:1995;478-481.
7. González-Juanatey J.R., Pose A., Garcìa J.M., Varela A., Calvo C., Cabezas-Cerrato J. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension. Am J Cardiol. 81:1998;87-90.
8. González-Juanatey J.R., García J.M., Pose A., Varela A., Calvo C., Cabezas-Cerrato J., Gil M. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. Am J Cardiol. 81:1998;170-174.
9. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in men anatomic validation of the method . Circulation. 55:1977;613-618.
10. Bazett H.C. An analysis of the time relations of electrocardiograms. Heart. 7:1920;353-370.
11. Schwartz P., Wolf S. QT interval prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation. 57:1978;1074-1077.
12. Hii J.T.Y., Wyse D.G., Gillis A.M., Duff H.J., Solylo M.A., Mitchell L.B. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation. 86:1992;1376-1382.
13. Buja G., Miorelli M., Turrini P., Melacini P., Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 72:1993;973-976.
14. Barr C.S., Naas A., Freeman M., Lang C.C., Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 343:1994;327-329.
15. Mayet J., Shahi M., McGrath K., Poulter N.R., Sever P.S., Foale R.A., Thom S.A.M. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension. 28:1996;791-796.
16. Ichkhan K., Molnar J., Somberg J. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol. 79:1997;508-511.
17. Mancini G.B.J., Henry G.C., Macaya C., O'Neill B.J., Pucillo A.L., Carere R.G., Wargovich T.J., Mudra H., Luscher T.F., Klibaner M.I., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation. 94:1996;258-265.
18. Gibbon G.H. Mechanisms of cardiovascular remodelling cardioprotective role of ACE inhibition . J Cardiovasc Pharmacol. 30:(suppl 1):1997;S1-S9.
19. Diez J., Panizo A., Hernandez M., Galindo M.F., Cenarruzabeitia E., Pardo F.J. Quinapril inhibits c-Myc expression and normalizes smooth muscle cell proliferation in spontaneously hypertensive rats. Am J Hypertens. 10:1997;1147-1152.
20. Rosendorff C. The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol. 28:1996;803-812.
21. Urata H., Healy B., Stewart R.W., Bumpus F.M., Husain A. Angiotensin II forming pathways in normal and failing human hearts. Cir Res. 66:1990;883-890.
22. Bao G., Gohlke P., Qadri F., Unger T. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension. 20:1992;74-79.
23. Kramer H.J., Glanzer K., Meyer-Lehnert H., Mohaupt M., Predel H.G. Kinin- and non kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones. J Cardiovasc Pharmacol. 15:(suppl 6):1990;S91-S98.